Acadian Asset Management
PMVP icon

Acadian Asset Management’s PMV Pharmaceuticals PMVP Stock Holding History

Acadian Asset Management’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.97M Hold
2,215,894
– – ﹤0.01% 952
2026
Q1 		$2.75M Buy
2,215,894
+200,124
+10% +$255K ﹤0.01% 870
2025
Q4 		$2.52M Sell
2,015,770
-50,367
-2% -$67.5K ﹤0.01% 851
2025
Q3 		$2.89M Hold
2,066,137
– – 0.01% 798
2025
Q2 		$2.19M Buy
2,066,137
+18,960
+0.9% +$18.6K ﹤0.01% 800
2025
Q1 		$2.23M Sell
2,047,177
-31,689
-2% -$43K 0.01% 728
2024
Q4 		$3.14M Hold
2,078,866
– – 0.01% 655
2024
Q3 		$3.09M Hold
2,078,866
– – 0.01% 625
2024
Q2 		$3.37M Sell
2,078,866
-1,328
-0.1% -$2.4K 0.01% 606
2024
Q1 		$3.53M Buy
2,080,194
+1,311,745
+171% +$2.45M 0.01% 540
2023
Q4 		$2.38M Buy
+768,449
New +$2.03M 0.01% 634

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Acadian Asset Management's PMVP Position: Q2 2026 in Review

Acadian Asset Management held its PMV Pharmaceuticals (PMVP) position steady in Q2 2026 at 2,215,894 shares worth $2.97M. The position accounts for ﹤0.01% of the portfolio, ranked #952.

Acadian Asset Management first reported a position in PMVP in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.53M in Q1 2024. 64 funds tracked by Wall St. Rank hold PMVP as of Q2 2026.

  • Acadian Asset Management held 2,215,894 shares of PMV Pharmaceuticals worth $2.97M as of Q2 2026.
  • Acadian Asset Management left its PMV Pharmaceuticals share count unchanged in Q2 2026.
  • PMV Pharmaceuticals made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #952 holding.
  • Acadian Asset Management first reported a position in PMV Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • Acadian Asset Management's PMV Pharmaceuticals position peaked at $3.53M in Q1 2024.
  • 64 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.